Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 5Recruiting 4Unknown 3Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Amenorrhea 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Postoperative Period × Clear all
NCT02075060 2017-04-06

IPOI vs IPOP

Poitiers University Hospital

Phase 2 Unknown
54 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT01503905 2016-05-24

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Unknown
600 enrolled
Breast

Amenorrhea, Breast Neoplasms

NCT00654342 2008-04-08

Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer

Chung-Ang University

Phase NA Unknown
100 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡